- Home
- Publications
- Publication Search
- Publication Details
Title
Oligonucleotides Targeting Telomeres and Telomerase in Cancer
Authors
Keywords
-
Journal
MOLECULES
Volume 23, Issue 9, Pages 2267
Publisher
MDPI AG
Online
2018-09-06
DOI
10.3390/molecules23092267
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA Regulation of Telomerase Reverse Transcriptase (TERT): Micro Machines Pull Strings of Papier-Mâché Puppets
- (2018) Ammad Farooqi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanism of Action of G-Quadruplex–Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma
- (2018) Gagan Chhabra et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- miR-128 inhibits telomerase activity by targeting TERT mRNA
- (2018) Herlinda Guzman et al. Oncotarget
- Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an “ALT-like” phenotype in diffuse malignant peritoneal mesothelioma cells
- (2017) Graziella Cimino-Reale et al. Journal of Hematology & Oncology
- Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
- (2017) Rachid El Fatimy et al. MOLECULAR THERAPY
- MiR-138: A promising therapeutic target for cancer
- (2017) Huan-Huan Sha et al. TUMOR BIOLOGY
- Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells
- (2017) Katrina M. Burchett et al. Oncotarget
- Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma
- (2017) Xuping Wu et al. Oncotarget
- Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
- (2017) Wenying Huo et al. Journal of Cancer
- Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs
- (2016) Matthew D. Disney et al. ACS Chemical Biology
- A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study
- (2016) Ralph Salloum et al. JOURNAL OF NEURO-ONCOLOGY
- MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer
- (2016) Na Zhou et al. Oncology Letters
- Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner
- (2016) Robin E. Frink et al. Oncotarget
- Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
- (2016) Mohammad A. Jafri et al. Genome Medicine
- Therapeutic Targeting of Telomerase
- (2016) Kathrin Jäger et al. Genes
- CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo
- (2016) Hong Chang et al. Scientific Reports
- Current Molecularly Targeting Therapies in NSCLC and Melanoma
- (2015) Supriya Rajanna et al. Anti-Cancer Agents in Medicinal Chemistry
- Prognostic Relevance of Human Telomerase Reverse Transcriptase (hTERT) Expression in Patients with Gall Bladder Disease and Carcinoma
- (2015) Raj Kumari Deblakshmi et al. Asian Pacific Journal of Cancer Prevention
- The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells
- (2015) Jillian E. Koziel et al. BREAST CANCER RESEARCH AND TREATMENT
- miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT
- (2015) Dan Zhang et al. CANCER LETTERS
- Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase
- (2015) Mark A. Babizhayev et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- MicroRNA-21 controls hTERT via PTEN in human colorectal cancer cell proliferation
- (2015) Yang Yang et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- MiR-21: an environmental driver of malignant melanoma?
- (2015) Bodo C Melnik Journal of Translational Medicine
- Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma
- (2015) Sylvain Ferrandon et al. Molecular Cancer
- Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer
- (2015) Cheng-Le Zhuang et al. TUMOR BIOLOGY
- miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells
- (2015) Takahito Ohira et al. Scientific Reports
- miR-346 and miR-138 competitively regulate hTERT in GRSF1- and AGO2-dependent manners, respectively
- (2015) Ge Song et al. Scientific Reports
- Telomere-Homologous G-Rich Oligonucleotides Sensitize Human Ovarian Cancer Cells to TRAIL-Induced Growth Inhibition and Apoptosis
- (2015) Sibaji Sarkar et al. Nucleic Acid Therapeutics
- Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma
- (2015) Ryan T Pitman et al. Oncotarget
- A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer
- (2014) A. A. Chiappori et al. ANNALS OF ONCOLOGY
- Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients
- (2014) Meike H. van der Ree et al. ANTIVIRAL RESEARCH
- T-oligo as an anticancer agent in colorectal cancer
- (2014) Luke Wojdyla et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy
- (2014) Zachary Crees et al. CURRENT PHARMACEUTICAL DESIGN
- Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
- (2014) Nishant S. Gandhi et al. JOURNAL OF CONTROLLED RELEASE
- Star-Shaped Tetraspermine Enhances Cellular Uptake and Cytotoxicity of T-Oligo in Prostate Cancer Cells
- (2014) Vidula Kolhatkar et al. PHARMACEUTICAL RESEARCH
- Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells
- (2014) Katrina M. Burchett et al. PLoS One
- MicroRNA-21 Regulates hTERT via PTEN in Hypertrophic Scar Fibroblasts
- (2014) Hua-Yu Zhu et al. PLoS One
- Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor
- (2014) Yafang Hu et al. Cancer Genetics
- Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
- (2014) Pedro M. D. Moreno et al. Frontiers in Chemistry
- Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
- (2013) R Bertorelle et al. BRITISH JOURNAL OF CANCER
- Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides
- (2013) Neelu Puri et al. CANCER LETTERS
- miR-128 and its target genes in tumorigenesis and metastasis
- (2013) Molin Li et al. EXPERIMENTAL CELL RESEARCH
- miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo
- (2013) Mrinmay Chakrabarti et al. EXPERIMENTAL CELL RESEARCH
- Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton
- (2013) ILGEN MENDER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Telomere Dynamics in Mice and Humans
- (2013) Rodrigo T. Calado et al. SEMINARS IN HEMATOLOGY
- MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN
- (2013) Lei Shen et al. TUMOR BIOLOGY
- Novel anticancer therapeutics targeting telomerase
- (2012) Maria Ruden et al. CANCER TREATMENT REVIEWS
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics
- (2012) José A. March-Villalba et al. PLoS One
- A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer
- (2011) Fabrizio Bianchi et al. EMBO Molecular Medicine
- Mechanism of T-oligo-induced cell cycle arrest in Mia-Paca pancreatic cancer cells
- (2011) Andrew M. Rankin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
- (2010) Felix Moltzahn et al. CANCER RESEARCH
- Telomere Shortening Sensitizes Cancer Cells to Selected Cytotoxic Agents: In Vitro and In Vivo Studies and Putative Mechanisms
- (2010) Orit Uziel et al. PLoS One
- The Effect of Telomerase Template Antagonist GRN163L on Bone-Marrow-Derived Rat Mesenchymal Stem Cells is Reversible and Associated with Altered Expression of Cyclin d1, cdk4 and cdk6
- (2010) Zeynep Tokcaer-Keskin et al. Stem Cell Reviews and Reports
- Inhibition of Melanoma Angiogenesis by Telomere Homolog Oligonucleotides
- (2010) Christina Coleman et al. Journal of Oncology
- Ionizing Radiation Up-regulates Telomerase Activity in Cancer Cell Lines by Post-translational Mechanism via Ras/Phosphatidylinositol 3-Kinase/Akt Pathway
- (2009) R. Ram et al. CLINICAL CANCER RESEARCH
- Lipid-conjugated telomerase template antagonists sensitize resistant HER2-positive breast cancer cells to trastuzumab
- (2008) Erin M. Goldblatt et al. BREAST CANCER RESEARCH AND TREATMENT
- Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines
- (2008) Shingo Mitomo et al. CANCER SCIENCE
- Actions of human telomerase beyond telomeres
- (2008) Yusheng Cong et al. CELL RESEARCH
- Targeting RNA with Small Molecules
- (2008) Jason R. Thomas et al. CHEMICAL REVIEWS
- Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: Mechanism and therapeutic potential
- (2008) Harold O. Longe et al. INTERNATIONAL JOURNAL OF CANCER
- State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers
- (2008) Elias Fattal et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo
- (2008) M A Shammas et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search